---
title: "Ascendis Pharma Issues New Employee Warrants"
date: "2025-02-13 04:49:00"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioAn announcement from Ascendis Pharma (..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1279492897-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

An announcement from Ascendis Pharma ( [(ASND)](https://www.tipranks.com/stocks/asnd) ) is now available.

On February 11, 2025, Ascendis Pharma’s board granted 31,040 warrants to its employees, allowing them to subscribe to ordinary shares at $119.51 per share. This move reflects the company’s ongoing commitment to employee incentives, with the warrants vesting over time, subject to continued service. Following this grant, nearly 1.95 million additional shares remain available for future issuance, indicating potential for further employee or strategic incentives.

**More about Ascendis Pharma**

Ascendis Pharma A/S is a company based in Denmark, focused on developing medical solutions for disease treatment. The company is involved in the manufacture and sale of pharmaceutical preparations and has a strategic interest in owning shares of similar companies.

**YTD Price Performance:** -13.40%

**Average Trading Volume:** 450,810

**Technical Sentiment Consensus Rating:** Hold

**Current Market Cap:** $7.14B

For a thorough assessment of ASND stock, go to [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/asnd/stock-analysis).

Trending Articles:
------------------

* [A New Joint Venture For Intel (NASDAQ:INTC)?](https://www.tipranks.com/news/a-new-joint-venture-for-intel-nasdaqintc)
* [Boeing (NYSE:BA) Astronauts Coming Home Early, Sort Of](https://www.tipranks.com/news/boeing-nyseba-astronauts-coming-home-early-sort-of)
* [Exxon Mobil (NYSE:XOM) Readies Guyana Expansion](https://www.tipranks.com/news/exxon-mobil-nysexom-readies-guyana-expansion)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/ascendis-pharma-issues-new-employee-warrants)
